Mesa Air Group (NASDAQ:MESA) Bolsa

Mesa Air Gr

Mesa Air Group Inc is a regional air carrier providing scheduled passenger service. It provides services to the District of Columbia, Canada, Cuba, and Mexico, and cargo services out of Cincinnati/Northern Kentucky International Airport. Flights are operated as American Eagle, United Express, or DHL Express flights to the terms of capacity purchase agreements with American and United and a flight services agreement with DHL. The business has a presence in domestic hubs and cities, including Dallas, Houston, Phoenix, and Washington-Dulles, and other regions.

Mesa Air Group Inc

MESA HOME RESOURCES by Mesa Home Resources Inc.

Mesa Home Resources Inc

Mesa Laboratories Inc

Mesa Royalty Trust

Mesabi Trust

B of A Securities analyst Curtis Nagle maintains Zillow Gr (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/Z#NASDAQ">Z</a>) with a Neutral and raises the price target from $81 to $88.

News

Price Target

Analyst Ratings

B of A Securities Maintains Neutral on Zillow Gr, Raises Price Target to $88

Ironwood Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IRWD#NASDAQ">IRWD</a>) reported quarterly earnings of $0.14 per share which beat the analyst consensus estimate of $0.04 by 250 percent. This is a 1300 percent increase over earnings of $0.01 per share from the same period last year. The company reported quarterly sales of $85.239 million which beat the analyst consensus estimate of $60.775 million by 40.25 percent. This is a 9.70 percent decrease over sales of $94.396 million the same period last year.

Earnings

Earnings Beats

IRWD

Ironwood Pharmaceuticals Q2 Adj. EPS $0.14 Beats $0.04 Estimate, Sales $85.239M Beat $60.775M Estimate

ACRS

Aclaris Therapeutics Q2 EPS $(0.13) Beats $(0.14) Estimate, Sales $1.777M Beat $1.435M Estimate

In 2021, on an episode of "The Ramsey Show," a young caller stunned personal finance expert Dave Ramsey with a $43,000 stock portfolio, but the financial expert had a surprising response.
<h2 class="wp-block-heading">Young Investor With $43,000 In Single Stocks Seeks Retirement Advice At 22</h2>
Nick, a 22-year-old caller, phoned into the show seeking retirement advice. His employer didn't offer a 401K, so he asked Ramsey whether he should open a traditional or Roth IRA. 
Nick revealed he had around $3,000 in savings and had invested $43,000, money received from a childhood accident settlement, mostly in single stocks through E-Trade.
<h2 class="wp-block-heading">Ramsey Warns Against Early Roth IRA Contributions Without Income Stability</h2>
Ramsey applauded Nick's initiative but expressed concern over his investment strategy and priorities.&nbsp;
"You're way ahead of the curve to be working on this at your age," he said, adding, "But you're taking too much risk, in my opinion." No more than 10% of your net worth should be in a single stock, Ramsey added.
The expert advised Nick to redirect his focus toward financial independence. "You do not need to start your Roth IRA yet," he said.
 "You need to pile up money to make the transition out of your household and complete your studies," Ramsey added.
Nick currently lives with his parents and earns about $15,000 a year through a work-study program. He said he doesn't plan to move out until age 26 to 28, prompting Ramsey to push back. "I don't want you 28 years old in your mother's basement, dude. Get out and get going."
<figure class="wp-block-embed is-type-video is-provider-youtube wp-block-embed-youtube wp-embed-aspect-16-9 wp-has-aspect-ratio"> 
<div class="wp-block-embed__wrapper">
<iframe loading="lazy" title="I&#039;m 23, How Should I Be Investing?" width="500" height="281" src="https://www.youtube.com/embed/VjgWbcpVZVw?feature=oembed" frameborder="0" allow="accelerometer; autoplay; clipboard-write; encrypted-media; gyroscope; picture-in-picture; web-share" referrerpolicy="strict-origin-when-cross-origin" allowfullscreen></iframe>
</div>
</figure>
See Also:&nbsp;<a href="https://benzinga.com/news/25/06/45853487/border-czar-tom-homan-says-no-intention-to-arrest-gavin-newsom-despite-trumps-remarks-they-havent-crossed-a-" target="_blank" rel="noreferrer noopener">Border Czar Tom Homan Says ‘No Intention' To Arrest Gavin Newsom Despite Trump's Remarks: ‘They Haven't Crossed A Line Yet'</a>
<h2 class="wp-block-heading">Ramsey Says Lack Of Hope, Not Knowledge, Is Why People Fail Financially</h2>
In a 2023 interview on The Iced Coffee Hour podcast, Ramsey said the biggest barrier to wealth-building isn't knowledge, but a lack of hope.&nbsp;
Many people avoid saving or budgeting because they don't believe their <a href="https://www.benzinga.com/personal-finance/financial-advisors/25/08/46851867/dave-ramsey-says-most-people-stay-broke-because-theyve-lost-hope-not-because-they-cant-do-the-math">efforts will lead to financial success</a>. "I don't believe if I save money, I can really be a millionaire," Ramsey explained.&nbsp;
Using a farming analogy, he emphasized that just like planting corn requires faith in a harvest, financial progress depends on believing change is possible. Ramsey said restoring that hope is central to his show's mission.
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/analyst-stock-ratings/analyst-color/25/07/46192421/home-health-braces-for-potential-1-billion-cut-in-medicare-payments" target="_blank" rel="noreferrer noopener">Home Health Braces For Potential $1 Billion Cut In Medicare Payments</a></li>
</ul>
Disclaimer:&nbsp;This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.
Image via Imagn

Financial Advisors

'You're Way Ahead, But...' — Dave Ramsey Surprised By 22-Year-Old's $43,000 Stock Bet, Issues Blunt Warning

WIIM

PTON

Peloton Interactive shares are trading higher after the company reported better-than-expected Q4 EPS and sales.

Cullinan Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CGEM#NASDAQ">CGEM</a>) reported quarterly losses of $(1.07) per share which missed the analyst consensus estimate of $(0.84) by 26.93 percent. This is a 57.35 percent decrease over losses of $(0.68) per share from the same period last year.

Earnings Misses

CGEM

Cullinan Therapeutics Q2 EPS $(1.07) Misses $(0.84) Estimate

Avalo Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AVTX#NASDAQ">AVTX</a>) reported quarterly losses of $(1.92) per share which missed the analyst consensus estimate of $(1.42) by 35.5 percent. This is a 86.35 percent increase over losses of $(14.07) per share from the same period last year.

AVTX

Avalo Therapeutics Q2 EPS $(1.92) Misses $(1.42) Estimate; Cash, Cash equivalents And Short-term Investments Were $113.3M As Of June 30

LLY: -14% &#x7C; <a href="https://www.benzinga.com/node/46956346">Eli Lilly and Company shares are trading lower after the company announced topline results from the Phase 3 ATTAIN-1 trial evaluating orforglipron in adults with obesity.</a>
&nbsp;
VKTX: 15% &#x7C; <a href="https://www.benzinga.com/node/46956789">Viking Therapeutics, shares are trading higher in reaction to Lilly's Phase 3 ATTAIN-1 trial results of orforglipron in adults with obesity.</a>
&nbsp;
CELH: 20% &#x7C; <a href="https://www.benzinga.com/node/46955195">Celsius Holdings shares are trading higher after the company reported better-than-expected Q2 EPS and sales results.</a>

Movers

Trading Ideas

CELH

VKTX

Market-Moving News for August 7th

HC Wainwright &amp; Co. analyst Swayampakula Ramakanth maintains Delcath Systems (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DCTH#NASDAQ">DCTH</a>) with a Buy and raises the price target from $29 to $31.

DCTH

HC Wainwright & Co. Maintains Buy on Delcath Systems, Raises Price Target to $31

Telsey Advisory Group analyst Dana Telsey maintains Capri Holdings (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CPRI#NYSE">CPRI</a>) with a Market Perform and raises the price target from $20 to $22.

CPRI

Telsey Advisory Group Maintains Market Perform on Capri Holdings, Raises Price Target to $22

Insulet (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PODD#NASDAQ">PODD</a>) sees Q3 sales of $663.558 million-$679.875 million vs $645.86 million analyst estimate.

Guidance

PODD

Insulet Sees Q3 Sales $663.558M-$679.875M vs $645.86M Est

TLRY

Tilray Wellness Introduces The Humble Seed Crackers Featuring Hemp, Chia, Flax, And Pumpkin Seeds For Protein-Forward Snacking

Rapport Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RAPP#NASDAQ">RAPP</a>) reported quarterly losses of $(0.75) per share which beat the analyst consensus estimate of $(0.85) by 11.45 percent. This is a 55.88 percent increase over losses of $(1.70) per share from the same period last year.

RAPP

Rapport Therapeutics Q2 EPS $(0.75) Beats $(0.85) Estimate

The most oversold stocks in the energy sector presents an opportunity to buy into undervalued companies.
The RSI is a momentum indicator, which compares a stock&#8217;s strength on days when prices go up to its strength on days when prices go down. When compared to a stock&#8217;s price action, it can give traders a better sense of how a stock may perform in the short term. An asset is typically considered oversold when the<a href="https://www.benzinga.com/topic/rsi"> RSI is below 30</a>, according to <a href="https://pro.benzinga.com/">Benzinga Pro</a>.
Here's the latest list of major oversold players in this sector, having an RSI near or below 30.
<h3 class="wp-block-heading">Comstock Resources Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CRK#NYSE">CRK</a>)</h3>
<ul class="wp-block-list">
<li>On July 30, Comstock Resources posted in-line earnings for the second quarter. The company's stock fell around 32% over the past month and has a 52-week low of $8.64.</li>
<li>RSI Value: 24.4</li>
<li>CRK Price Action: Shares of Comstock Resources closed at $16.26 on Wednesday.</li>
</ul>
<h3 class="wp-block-heading">Propetro Holding Corp (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PUMP#NYSE">PUMP</a>)&nbsp;&nbsp;&nbsp;</h3>
<ul class="wp-block-list">
<li>On July 30, ProPetro Holding reported worse-than-expected second-quarter financial results. Sam Sledge, Chief Executive Officer, said, &#8220;In what proved to be a challenging quarter, we maintained operational and financial stability and continued to advance our strategy. Free cash flow for our completions business remained intact, supported by our capital-light investment strategy, cost control, and the consistent performance of the ProPetro team.&#8221; The company's stock fell around 23% over the past month and <a href="https://www.benzinga.com/quote/PUMP">has a 52-week low </a>of $4.61.</li>
<li>RSI Value: 29.5</li>
<li>PUMP Price Action: Shares of Propetro Holding fell 8.9% to close at $4.78 on Wednesday.</li>
<li>Benzinga Pro&#8217;s charting tool helped identify the trend in <a href="https://www.benzinga.com/pro/register?utm_adType=bzprocontent&amp;utm_campaign=14daytrial&amp;utm_ad=0807">PUMP stock</a>. </li>
</ul>
<figure class="wp-block-image size-full is-resized"><a href="https://www.benzinga.com/pro/register?utm_adType=bzprocontent&amp;utm_campaign=14daytrial&amp;utm_ad=0807"><img loading="lazy" decoding="async" width="923" height="818" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/08/07071419/image-120.png" alt="" class="wp-image-1018605" style="width:702px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/08/07071419/image-120.png 923w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/08/07071419/image-120-300x266.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/08/07071419/image-120-768x681.png 768w" sizes="(max-width: 923px) 100vw, 923px" /></a></figure>
<h3 class="wp-block-heading">Flowco Holdings Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FLOC#NYSE">FLOC</a>)</h3>
<ul class="wp-block-list">
<li>On Aug. 5, Flowco Holdings posted weak quarterly sales. Joe Bob Edwards, President and CEO, said, &#8220;Flowco delivered strong second-quarter results, with sequential improvements in both Adjusted EBITDA and Adjusted EBITDA Margins, while generating robust free cash flow. These results emphasize our differentiated financial profile and the disciplined operational execution of our business segments.&#8221; The company's stock fell around 15% over the past five days and has a 52-week <a href="https://www.benzinga.com/quote/FLOC">low of $15.58</a>.</li>
<li>RSI Value: 27.3</li>
<li>FLOC Ltd Price Action: Shares of Flowco dipped 10.1% to close at $15.97 on Wednesday.</li>
<li>Benzinga Pro&#8217;s signals feature notified of a potential breakout in <a href="https://www.benzinga.com/pro/register?utm_adType=bzprocontent&amp;utm_campaign=14daytrial&amp;utm_ad=0807">FLOC shares</a>. </li>
</ul>
<figure class="wp-block-image size-full is-resized"><a href="https://www.benzinga.com/pro/register?utm_adType=bzprocontent&amp;utm_campaign=14daytrial&amp;utm_ad=0807"><img loading="lazy" decoding="async" width="893" height="807" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/08/07071218/image-119.png" alt="" class="wp-image-1018602" style="width:706px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/08/07071218/image-119.png 893w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/08/07071218/image-119-300x271.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/08/07071218/image-119-768x694.png 768w" sizes="(max-width: 893px) 100vw, 893px" /></a></figure>
Learn more about BZ Edge Rankings—click to see scores for other stocks in the sector and s<a href="https://www.benzinga.com/premium/ideas/benzinga-edge-2#:~:text=Turn%20Market%20Chaos,when%20markets%20rebound">ee how they compare.</a>
Read This Next: 
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/trading-ideas/short-ideas/25/08/46896005/top-2-industrials-stocks-that-may-plunge-in-august">Top 2 Industrials Stocks That May Plunge In August</a></li>
</ul>
Photo via Shutterstock

Long Ideas

Pre-Market Outlook

Markets

FLOC

PUMP

Top 3 Energy Stocks Which Could Rescue Your Portfolio This Month

Buybacks

CCOI

Cogent Communications Approves $100M Increase To Buyback Program

Stifel analyst Nathan Jones upgrades ESAB (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ESAB#NYSE">ESAB</a>) from Hold to Buy and announces $141 price target.

Upgrades

ESAB

Stifel Upgrades ESAB to Buy, Announces $141 Price Target

GH Research (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GHRS#NASDAQ">GHRS</a>) reported quarterly losses of $(0.15) per share which beat the analyst consensus estimate of $(0.21) by 30.23 percent. This is a 25 percent increase over losses of $(0.20) per share from the same period last year.

GHRS

GH Research Q2 EPS $(0.15) Beats $(0.21) Estimate

CorMedix Inc. ("CorMedix") (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CRMD#NASDAQ">CRMD</a>), a biopharmaceutical company focused on developing and commercializing therapeutic products for life-threatening diseases and conditions, and Melinta Therapeutics LLC ("Melinta"), a private commercial-stage company providing innovative therapies for acute and life-threatening illnesses, today announced a definitive agreement for CorMedix to acquire Melinta. The selling shareholders will receive $300 million in total consideration at closing, including $40 million of CorMedix equity, and will be eligible to receive a regulatory milestone of up to $25 million and royalties on net sales of MINOCIN&#xAE; and REZZAYO&#x2122;.
The proposed acquisition will expand CorMedix's team and commercial platform, and increase the commercial portfolio with six marketed, highly differentiated, hospital- and clinic-focused infectious disease products, including REZZAYO&#x2122; (rezafungin for injection), MINOCIN&#xAE; (minocycline) for Injection, VABOMERE&#xAE; (meropenem and vaborbactam), KIMYRSA&#xAE; (oritavancin), ORBACTIV&#x2122; (oritavancin), BAXDELA&#xAE; (delafloxacin), and an additional well-established cardiovascular product, TOPROL-XL&#xAE; (metoprolol succinate). REZZAYO&#x2122; is currently approved for the treatment of candidemia and invasive candidiasis in adults, with an ongoing Phase III study for the prophylaxis of invasive fungal infections in adult patients undergoing allogeneic blood and marrow transplantation. The completion of the Phase III study for REZZAYO&#x2122; is expected in 1H 2026.

CRMD

Somnigroup International's CorMedix to Acquire Melinta in $300M Deal, Expanding Infectious Disease Portfolio

Telsey Advisory Group analyst Dana Telsey maintains Leslies (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LESL#NASDAQ">LESL</a>) with a Market Perform and lowers the price target from $0.75 to $0.35.

LESL

Telsey Advisory Group Maintains Market Perform on Leslies, Lowers Price Target to $0.35

Warner Bros. Discovery Q2 EPS $0.63 May Not Compare To $(0.22) Estimate, Sales $9.81B Beat $9.72B Estimate

Press Releases

SHAREHOLDER ALERT: The M&A Class Action Firm Investigates the Merger of Mesa Air Group, Inc. - MESA

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates ICAD, XAGE, DADA, MESA on Behalf of Shareholders

Legal

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates COOP, OPTN, AZEK, MESA on Behalf of Shareholders

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates COOP, MESA, DADA on Behalf of Shareholders

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates PRA, COOP, MESA on Behalf of Shareholders

Mesa Air Group Reports Fourth Quarter and Fiscal Full-Year 2024 Results

Mesa Air Group Reports First Quarter Fiscal 2025 Results

Mesa Air Group Reports Second Quarter Fiscal 2025 Results

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates NVEE, ENZB, MESA, HSON on Behalf of Shareholders

Mesa Air Group Files Registration Statement on Form S-4 and S-1 in Connection with Proposed Merger with Republic Airways Holdings Inc.

AZEK

COOP

DADA

ENZB

HSON

ICAD

MESA

NVEE

OPTN

XAGE

American Airlines Group, Inc. - Common Stock

American Airlines Group

Allegiant Travel

Alaska Air Gr

Blade Air Mobility, Inc. - Class A Common Stock

Blade Air Mobility

Copa Holdings

Delta Air Lines

flyExclusive

JetBlue Airways Corporation - Common Stock

JetBlue Airways

Joby Aviation

Jet AI

LATAM Airlines Group S.A. American Depositary Shares (each representing two thousand (2,000) shares of Common Stock)

LATAM Airlines Group

Southwest Airlines

Mesa Air Group

Ryanair Holdings plc - American Depositary Shares, each representing five Ordinary Shares

Ryanair Hldgs

SkyWest

Sun Country Airlines Holdings, Inc. - Common Stock

Sun Country Airlines

Volato Group

Surf Air Mobility

United Airlines Holdings, Inc. - Common Stock

United Airlines Holdings

Frontier Group Holdings, Inc. - Common Stock

Frontier Group Holdings

Wheels Up Experience Inc. Class A Common Stock

Wheels Up Experience

Controladora Vuela Compania de Aviacion, S.A.B. de C.V. American Depositary Shares, each representing ten (10) Ordinary Participation Certificates

Controladora Vuela

Deutsche Bank

Cowen & Co.

Comments

Mesa Air Group

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL